Food Causing Physical Stress
In Short ;
Due to the influence of heat, prepared foods contain both anesthetizing and stimulating substances, causing conflicting messages in the brain. Wheat- and dairy-products
by nature also contain anesthetizing substances.
Because the food we eat in general contains more anaesthetizing than stimulating substances, most adults are numb and apathetic. But at the same time the absorbed stimulating substances cause stress and aggression.
Young children continuously fight against both the stimulating and oppressing food-substances,
which may cause hyperactivity. These children can't keep focused due to receiving conflicting messages all the time, what we call ADHD (Attention Deficit Hyperactivity Disorder). ADHD is not a miraculously increased 'psychological disease', but is caused by chemicals in our
In Detail ;
Our food contains different chemicals influencing functioning of our brain;
Due to the influence of heat, new substances originate from the preparation of food.
A part of these new substances are beta-carbolines (1). The more protein the food contains, the more beta-carbolines originate. Therefore, prepared meat, -fish, -soy and -eggs etc., contains the most beta-carbolines.
There generally are three types of beta-carbolines: ‘downers', 'uppers' and 'anti's'.
It has been known for almost 20 years that beta-carbolines cause physical stress
(2), and can disturb sleep (3).
But why are we sensitive to those beta-carbolines? Because the human body also composes and uses beta-carbolines as neurotransmitters, regulating secretion of a number of other neurotransmitters.Some (beyondveg.com) say exogenous beta-carbolines are not dangerous solely because the body also composes beta-carbolines. But they forget that through consuming prepared food, exogenous beta-carbolines enter the brain, impairing natural beta-carboline level. (like absorbing exogenous hormones impairs natural hormone metabolism, to prevent pregnancy for example) Moreover, 99% of prepared food originated beta-carbolines are different from endogenous ones, influencing our brain and behavior in an unpredictable manner. The results however, are very clear : ADHD in children, and stress, apathy, aggression and distorted sexual behavior in adults.
beta-Carbolines regulate acetylcholine secretion through the benzodiazepine-GABA complex and through the secretion of GABA (a neurotransmitter). Acetylcholine is a primal neurotransmitter, involved in our behavior, cognitive functions and muscle contractions. Acetylcholine is made of choline, and the transportation of choline is also regulated by beta-carbolines.
(4) beta-Carbolines also influence secretion and decomposition of other neurotransmitters, like serotonine, dopamine and norepinephrine. (see this page)
Just a small part of the absorbed beta-carbolines reach the brain (5), and less than 1% of the absorbed beta-carbolines can influence the benzodiazepine (BZD)-receptors
(6). But unfortunately this doesn't make much of a difference ; Because beta-carbolines regulate the level of other neurotransmitters, the concentration of beta-carbolines in the brain is 100 to 1000 times lower than the concentration of regular neurotransmitters like serotonine and dopamine.
(7) This means that a tiny little bit of beta-carbolines can have enormous effects.Some beta-carbolines also remain active for a very long time
Drugs acting equally, and through the same receptors, ''benzodiazepines'', have been under scrutiny and attack over recent years because of their abuse liability and withdrawal reactions.
(9) (see : benzodiazepines.cc)
Food Causing Physical Stress
Roughly, there are three kinds of beta-carbolines : 'downers', 'uppers' and 'anti's' ;
‘Downers’ (so-called ‘agonists’, inhibiting acetylcholine secretion)
In general, these 'downers' are physically addictive (10) ; if you don't absorb as much 'downers' as you are used to, you become annoyed and impatient. (11) ‘Downers' also are sedative (12), hypnotic (13), suppress respiration (14), and stimulate appetite (15). 'These downers' make you lose concentration (16) and cause memory-lapses (17), like alcohol also does through the same receptors. (18)
Some 'downers' suppress initiating behavior (19), inhibit social behavior (20), promote aggression in dominant individuals (21) or impair REM-sleep. (22)
Many tranquilizers (like valium) are exactly such 'downers'.
By nature the body itself produces 'downers' to promote submissive behavior, after having lost a fight against a competitor. (23)
'Uppers' (so-called 'inverse agonists', enhancing acetylcholine secretion)
These 'uppers' can enhance cocaine action ,partly by influencing the same receptors.(24) Like cocaïne also influences benzodiazepine-receptors. (25) In general 'uppers' have the same effect as physical or emotional stress (26), through impairing secretion and decomposition of dopamine (27), like cocaine does. (28) And those 'uppers' therefore influence our sexual behavior (29) and can cause sleeplessness
(30) and concentration-and memory-lapses. (31) 'Uppers' cause anxiety
(32), fear (33), promote aggressive behavior (34), and inhibit social behavior.
(35) 'Uppers' are addictive only indirectly. (36)
'Anti's' (so-called 'antagonists', eliminating action of both 'downers' and 'uppers')
'Anti's' inhibit action of both 'uppers' and 'downers' (inhibiting natural neurotransmitters too) 'Anti's' are addictive because they stimulate secretion of opioid peptides composed by the body (endorphins) (37). Some 'anti's' and other beta-carbolines inhibit recovery of damaged DNA. (38) When in stress, the body itself produces 'anti's’ to fight it. (39)
Though this classification may seem surveyable, unfortunately it isn't. Scientists always tried to conveniently arrange beta-carbolines, for commercial purposes. Unfortunately these beta-carbolines (and the so-called 'benzodiazepines') don't cooperate that well ;
- Interaction between receptors and neurotransmitters differs by the region in the brain (40).
- Through the continuous influence of beta-carbolines, 'downers' can become 'uppers' or 'anti's', and the other way around. (41)
- 'Downers' can make the receptors become more susceptible to 'uppers'.(42)
- Small amounts of beta-carbolines mostly have effects opposite to larger amounts of the same beta-carbolines. (43)
- Mixing different types of beta-carbolines, can change their effects.(44)
- And all this again differs by the region. (45)
- Every individual will react differently with beta-carbolines. However : (in mice) in general the sensitive and less active and -investigative individuals are more sensitive to those beta-carbolines that make you aggressive. And that the less sensitive and -intelligent, and more active and investigative individuals are more sensitive to those beta-carbolines that make you passive. (46)
So, beta-carbolines turn us into grey mice.
Normally, the BZD-receptors do not become less sensitive when we grow old. (47) But some beta-carbolines are very poisonous to brain-receptors.
(48) When BZD-receptors die, the remaining ones become more sensitive (49), so you won’t notice it. Until too many receptors have died. When the number of BZD-receptors decreases, feelings of anxiety
(50) and even panic (51), increase. This explains why so many elderly eventually become anxious.
Some beta-carbolines promote craving for alcohol. (52) A tolerance for 'downers' causes a tolerance for alcohol.
(53) Alcohol changes sensitivity of the BZD-receptors (54), in favor of the 'uppers'
(55). In small doses alcohol acts like an 'upper', promoting aggression. In larger doses alcohol is sedative, like 'downers'.
(56) Both the regular use of alcohol (57) and the absorption of 'uppers'
(58) suppresses the immune system.
Besides beta-carbolines, many other heterocyclic amines originate during the preparation process, such as pyrazoloquinolines
(59). Like beta-carbolines, quinolines can be addictive (60), change our behavior and impair hormone-balance
(61), through influencing the BZD-GABA-complex and NMDA-receptors. Some stimulate appetite.
ADHD is caused by beta-carbolines from prepared food, causing conflicting messages in the brain.
Because beta-carbolines in particular can impair serotonine- (63), dopamine-
(27) and norepinephrine (64) metabolism, logically, in ADHD, metabolism of serotonine
(65), dopamine (66) and / or norepinephrine (67) is impaired. Whether a child will show ADHD behavior depends on the sensitivity of its neurotransmitter-receptors.
(68) Opioid peptides also can impair serotonine (69) and norepinephrine
Pharmaceutical companies develop ADHD drugs that countereffect the effects of beta-carbolines and opioid peptides on these brain-receptors. Their drugs target serotonine, dopamine and / or norepinephrine metabolism. Of course they will not tell you what impaired that metabolism in the first place, since they just want you to buy their drugs.
To decrease intake of opioid peptides, one has to decrease intake of dairy- and wheat-products. (humans do not need mother's milk from other mammals. In fact, cow's milk contains 4-fold more calcium than human
milk, which increases
both formation and turnover of bone, accelerating the aging process.
To decrease intake of beta-carbolines, one has to consume less prepared foods, and proteinous prepared foods in particular.
(don't be afraid to absorb too little protein; even consuming fruits only, you will lack energy before you can possibly lack protein.
© 2000-2005 Copyright Artists Cooperative Groove Union U.A.
Home + navigation bar:
or without frames:
(1) Wang, M. et al, Two novel ß-carboline compounds from the maillard reaction between xylose and tryptophan. Journal of Agriculture and Food Chemistry 1999 / 47 () / 48-50. , Skog, K. et al, Analysis of nonpolar heterocyclic amines in cooked foods and meat extracts using gas chromatography-mass spectometry. J. Chromatogr. A. 1998 / 803 (1-2) / 227-233. , Herraiz, T. et al, Presence of tetrahydro-beta-carboline-3-carboxylic acids in foods by gas chromatography-mass spectometry as their N-methoxycarbonylmethyl ester derivates. J. Chromatogr. A. 1997 / 765 (2) / 265-277. , Wakabayashi, K. et al, Human exposure to mutagenic / carcinogenic heterocyclic amines and comutagenic beta-carbolines. Mutat. Res. 1997 / 376 (1-2) / 253-259. , Herraiz,T.,Occurence of tetrahydro-ß-carboline-3-carboxylic acids in commercial foodstuffs, Journal of Agricultural Food Chemistry 1996 / 44 / 3057-3065. , Papavergou, E. et al, Tetrahydro-beta-carboline-carboxylic acids in smoked foods. Food Addit. Contam. 1992 / 9 (1) / 83-95. , Sen, N.P. et al, Analytical methods for the determination and mass spectometric confirmation of 1-methyl-2-nitroso-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid and 2-nitroso-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid in foods. Food. Addit. Contam. 1991 / 8 (3) / 275-289. , Adachi, J. et al, Identification of tetrahydro-beta-carbolin-3-carboxylic acid in foodstuffs, human urine and human milk. J. Nutr. 1991 / 121 (5) / 646-652. , Rommelspacher, H. et al, Pharmacology of harmalan (1-methyl-3,4-dihydro-beta-carboline). Eur. J. Pharmacology 1985 / 109 (3) / 363-371. , Rommelspacher, H. et al, Is there a correlation between the concentration of beta-carbolines and their pharmacolodynamic effects ? Prog. Clin. Biol. Res. 1982 / 90 / 41-55. , Airaksinen, M.M. et al, Affinity of beta-carboline on rat brain benzodiazepine and opiate binding sites. Med. Biol. 1980 / 58 (6) / 341-344. , Proliac, A. et al, Isolation and identification of two beta-carbolins in roasted chicory root. Helv. Chim. Acta 1976 / 59 (7) / 2503-2507. (french)
(2) Biggio, G. et al, Stress and beta-carbolines decrease the density of low affinity GABA binding sites ; an effect reversed by diazepam. Brain. Res. 1984 / 305 (1) / 13-18.
(3) Skolnick, P. et al, New concepts in the neurobiology of anxiety. J. Clin. Psychiatry 1983 / 44 (11 pt 2) / 12-20.
(4) Walsh, T.J. et al, Intraseptal injection of GABA and benzodiazepine receptor ligands alters high affinity choline transport into the hippocampus. Brain. Res. Bull. 1993 / 31 (3-4) / 267-271.
(5) Fehske, K.J. et al, beta-Carboline inhibitor of benzodiazepine receptor binding in vitro. Brain. Res. 1982 / 238 (1) / 286-291.
(6) Krause, W. et al, Pharmacokinetics of two partial benzodiazepine receptor agonistic beta-carboline derivates in healthy volunteers. Arzneimittelforschung. 1993 / 43 (5) / 511-515.
(7) Rommelspacher, H. et al, beta-Carbolines and tetrahydroisoquinolines : detection and function in mammals. Planta. Med. 1991 / 57 (7) / 585-592.
(8) Lutes, J. et al, Tolerance to the tremorogenic effects of harmiline : evidence for altered olivo-cerebellar function. Neuropharmacology 1988 / 27 (8) / 849-855.
(9) Argypoulos, S.V. et al, The use of benzodiazepines in anxiety and other disorders. Eur. Neuropsychopharmacol. 1999 / 6 / 407-412.
(10) Loscher, W. et al, Withdrawal precipation by benzodiazepine receptor antagonists in dogs chronically treated with diazepam or the novel anxiolytic and anticonvulsant beta-carboline abecarnil. Naunyn Schmiedebergs Arch. Pharmacol. 1992 / 345 (4) / 452-460. , Eisenberg, R.M. et al, Effects of beta-carboline-ethyl ester on plasma corticosterone -- a parallel with antagonist-precipated diazepam withdrawal. Life Sci. 1989 / 44 (20) / 1457-1466.
(11) Little, H.J. et al, The benzodiazepines : anxiolytic and withdrawal effects. Neuropeptides 1991 / 19 / suppl. 11-14.
(12) Bianchi, M. et al, Peripherally administrated benzodiazepines increase morphine-induced analgesia in the rat. Arch. Int. Pharmacodyn. Ther. 1993 / 322 / 5-13. , Marescaux, C. et al, Bidirectional effects of the beta-carbolines in rats with spontaneous petit mal-like seizures. Brain. Res. Bull. 1987 / 19 (3) / 327-335.
(13) Tokuyama, S. et al, Blockade of the development of analgesic tolerance to morphine by psychological stress through benzodiazepine receptor mediated mechanism. Jpn. J. Pharmacol. 1989 / 51 (3) / 425-427. , Weber, K.H. et al, Pharmacological and neurochemical properties of 1,4-diazepines with two annelated heterocycles ('hetrazepines'). Eur. J. Pharmacol. 1985 / 109 (1) / 19-31. Kaijima, M. et al, Hypnotic action of ethyl-beta-carboline-3-carboxylate, a benzodiazepine receptor antagonist, in cats. Electroencephalogr. Clin. Neurophysiol. 1984 / 58 (3) / 277-281.
(14) Wettstein, J.G. et al, Respiratory effects of benzodiazepine-related drugs in awake rhesus monkeys. J. Pharmacol. Exp. Ther. 1990 / 255 (3) / 1328-1334.
(15) Yasui, M. et al, Benzodiazepine inverse agonists augment long-term potentiation in CA1 and CA3 of guinea pig hippocampal slices. Neuropharmacology 1993 / 32 (2) / 127-131. , Cooper, S.J. et al, The beta-carboline abecarnil, a novel agonist at central benzodiazepine receptors, influences sacharin and salt taste preferences in the rat. Brain. Res. 1992 / 599 (1) / 144-147. , Kreeger, T.J. et al, Diazepam-induced feeding in ceptive grey wolves (Canis Lupus). Pharmacol. Biochem. Behav. 1991 / 39 (3) / 559-561. , Cooper, S.J. ,Hyperphagic and anorectic effects of beta-carbolines in a palatable food consumption test : comparisons with triazolam and quazepam. Eur. J. Pharmacol. 1986 / 120 (3) / 257-265. , File, S.E. et al, Actions of the beta-carboline ZK93426 in an animal test of anxiety and the holeboard : interactions with Ro15-1788. J. Neural. Transm. 1986 / 65 (2) / 103-114.
(16) Hege, S.G. et al, Psychomotor effects of the anxiolytic abecarnil : a comparison with lorazepam. Psychopharmacology (Berl.) 1997 / 131 (2) / 101-107. , Mumford, G.K. et al, Abecarnil and alprazolam in humans : behavioral, subjective and reinforcing effects. J. Pharmacol. Exp. Ther. 1995 / 272 (2) / 570-580. , Duka, T. et al, Human studies on abecarnil, a new beta-carboline anxiolytic : safety, tolerability and preliminary pharmacological profile. Br. J. Clin. Pharmacol. 1993 / 35 (4) / 386-394.
(17) Stephens, D.N. et al, Bidirectional nature of benzodiazepine receptor ligands extends to effects on vigilance. Psychopharmacol. Ser. 1988 / 6 / 205-217. , Jensen, L.H. et al, Bidirectional effects of beta-carbolines and benzodiazepines on cognitive processes. Brain. Res. Bull. 1987 / 19 (3) 359-364.
(18) Borde, N. et al, Effects of methyl-beta-carboline-3-carboxylic acid on memory impairments induced by chronic alcohol consumption in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 1996 / 20 (8) / 1377-1387.
(19) Merlo Pick ,E. et al, A two compartment exploratory model to study anxiolytic / anxiogenic effects of drugs in the rat. Pharmacol. Res. 1989 / 21 (5) / 595-602.
(20) Chermat, R. et al, Interactions of Ginkgo biloba extract (EGb 761), diazepam and ethyl-beta-carboline-3-carboxylate on social behaviour of the rat. Pharmacol. Biochem. Behav. 1997 / 56 (2) / 333-339. , Maestripieri, D. et al, Anxiety in rhesus monkey infants in relation to interactions with their mother and other social companions. Dev. Psychobiol. 1991 / 24 (8) / 571-581. , Hindley, S.W. et al, The effects of methyl-beta-carboline-3-carboxylate on social interaction microinjected into the nucleus raphe dorsalis of the rat. Br. J. Pharmacol. 1985 / 86 (3) / 753-761.
(21) Vellucci, S.V. et al, The effect of midazolam and beta-carboline-3-carboxylate methyl ester on behaviour, steroid hormones and central monoamine metabolites in social groups of talapoin monkeys. Psychopharmacology (Berl.) 86 / 90 (3) / 367-372.
(22) Coenen, A.M. et al, Effects of the beta-carboline abecarnil on epileptic activity, EEG, sleep and behaviour of rats. Pharmacol. Biochem. Behav. 1992 / 42 (3) / 401-405.
(23) Rodgers, R.J. et al, Are the analgesic effects of social defeat mediated by benzodiazepine receptors ? Physiol. Behav. 1987 / 41 (3) / 279-289
(24) Ushijiama, I. et al, Cocaine : evidence for NMDA, beta-carboline- and dopaminergic-mediated seizures in mice. Brain. Res. 1998 / 797 (2) / 347-350.
(25) Giorgetti, M. et al, Imidazenil, a positive allosteric GABA-A receptor modulator, inhibits the effects of cocaine on locomotor activity and extracellular dopamine in the nucleus accumbens shell without tolerance liability. J. Pharmacol. Exp. Ther. 1998 / 287 (1) / 58-66. , Goeders, N.E. et al, Tolerance and sensitization to the behavioral effects of cocaine in rats : relationship to benzodiazepine receptors. Pharmacol. Biochem. Behav. 1997 / 57 (1-2) / 43-56.
(26) Soltis, R.P. et al, Cardiovascular effects of the beta-carboline FG7142 in borderline hypertensive rats. Physiol. Behav. 1998 / 63 (3) / 407-412. , Serrano, A. et al, NMDA antagonists block restraint-induced increase in extracellular DOPAC in rat nucleus accumbens. Eur. J. Pharmacol. 1989 / 162 (1) / 157-166. , Claustre, Y. et al, Pharmacological studies on stress-induced increase in frontal cortical dopamine metabolism in the rat. J. Pharmacol. Exp. Ther. 1986 / 238 (2) / 693-700.
(27) Kureta, Y. et al, Influence of social dominance on self-stimulation behavior in male golden hamster. Physiol. Behav. 1996 / 59 (4-5) / 621-624. , Horger, B.A. et al, Selective increase in dopamine utilization in the shell subdivision of the nucleus accumbens by the benzodiazepine inverse agonist FG7142. J. Neurochem. 1995 / 65 (2) / 770-774. , Concas, A. et al, Carbondioxide inhalation, stress and anxiogenic drugs reduce the function of GABAA receptor complex in the brain. Prog. Neuropsychopharmacol. Biol. Psychiatry 1993 / 17 (4) / 651-661. , Simon, P. et al, Anxiogenic-like effects induced by stimulation of dopamine receptors. Pharmacol. Biochem. Behav. 1993 / 45 (3) / 685-690. , Deutch, A.Y. et al, Stress selectively increases fos protein in dopamine neurons innervating prefrontal cortex. Cereb. Cortex. 1991 / 1 (4) / 273-292. , Bradberry, C.W. et al, The anxiogenic beta-carboline FG7142 selectively increases dopamine release in rat prefrontal cortex as measured by microdialysis. J. Neurochem. 1991 / 56 (2) / 748-752. , Tam, S.Y. et al, Modulation of mesoprefrontal dopamine neurons by central benzodiazepine receptors. !. Pharmacological characterization. J. Pharmacol. Exp. Ther. 1990 / 252 (3) / 989-996. , Tam, S.Y. et al, Modulation of mesoprefrontal dopamine neurons by central benzodiazepine receptors. !. Pharmacological characterization. J. Pharmacol. Exp. Ther. 1990 / 252 (3) / 989-996.Zetterstrom, T. et al, Local administration of flurazepam has different effects on dopamine release in striatum and nucleus accumbens : a microdialysis study. Neuropharmacology 1990 / 29 (2) / 129-134. , Giorgi, O. et al, Ro15-4513, like anxiogenic beta-carbolines, increases dopamine metabolism in the prefrontal cortex of the rat. Eur. J. Pharmacol. 1988 / 156 (1) / 71-75. ,Biggio, G. et al, Changes in GABAergic transmission induced by stress ,anxiogenic and anxiolytic beta-carbolines. Brain. Res. Bull. 1987 / 19 (3) / 301-308. , Stanford, S.C. et al, A single dose of FG7142 causes long-term increase in mouse cortical adrenoceptors. Eur. J. Pharmacol. 1987 / 134 (3) / 313-319. , Ida, Y. et al, The activation of mesoprefrontal dopamine neurons by FG7142 is absent in rats treated chronically with diazepam. Eur. J. Pharmacol. 1987 / 137 (2-3) / 185-190.
(28) Wyatt, R.J. et al, Effects of antipsychotics, vitamin E, and MK-801 on dopamine dynamics in the rat brain following discontinuation of cocaine. Psychiatry Res. 1998 / 80 (3) / 213-225.
(29) Fernandez-Guasti, A. et al, Anxiolytics reverse the acceleration of ejaculation resulting from enforced intercopulatory intervals in rats. Behav. Neurosci. 1991 / 105 (2) / 230-240.
(30) Ojima, K. et al, Flumazenil reverses the decrease in the hypnotic activity of pentebarbital by social isolation stress : are endogenous benzodiazepine receptor ligands involved ? Brain. Res. 1997 / 745 (1-2) / 127-133. , Duka, T. et al, Effects of ZK93,426, a beta-carboline benzodiazepine receptor antagonist on night sleep pattern in healthy male volunteers. Psychopharmacology (Berl.) 1995 / 117 (2) / 178-185.
(31) Murphy, B.L. et al, Dopamine and spatial working memory in rats and monkeys : pharmacological reversal of stress-induced impairment. J. Neurosci. 1996 / 16 (23) / 7768-7775.
(32) Duka, T. et al, Human studies on the benzodiazepine receptor antagonist beta-carboline ZK93426 : antagonism of lormetazepam's psychotropic effects. Psychopharmacology (Berl.) 1988 / 95 (4) / 463-471. , Dorow, R. et al, Clinical perspectives of beta-carbolines from first studies in humans. Brain. Res. Bull. 1987 / 19 (3) / 319-326.
(33) Fanselow, M.S. et al, The benzodiazepine inverse agonist DMCM as an unconditional stimulus for fear-induced analgesia : implications for the role of GABAA receptors in fear-related behaviour. Behav. Neurosci. 1992 / 106 (2) / 336-344.
(34) Holley, L.A. et al, Dissociation between the attentional effects of infusions of a benzodiazepine receptor agonist and inverse agonist into the basal forebrain. Psychopharmacology (Berl.) 1995 / 120 (1) / 99-108. , Hill, T.J. et al, beta-carboline and pentylenetetrazol effects on conflict behaviour in the rat. Pharmacol. Biochem. Behav. 1992 / 42 (4) / 733-736. , Shekhar, A. et al, Anxiogenic effects of noreleagnine, a water soluble beta-carboline in rats. Neuropharmacology 1989 / 28 (5) / 539-542. , Shibata, S. et al, Effects of benzodiazepine and GABA antagonists on anticonflict effects of antianxiety drugs injected into the rat amygdala in a water-lick suppression test. Psychopharmacology 1989 / 98 (1) / 38-44. , Adamec, R., Modelling anxiety disorder following chemical exposures. Toxicol. Ind. Health. 1994 / 10 (4-5) / 391-420. , Hodges, H. et al, Are the effects of benzodiazepines on discrimination and punishment dissociable ? Physiol. Behav. 1987 / 41 (3) / 257-264. , Corda, M.G. et al, Long-lasting proconflict effects induced by chronic administration of the beta-carboline derivate FG7142. Neurosci. Lett. 1985 / 62 (2) / 237-240.
(35) Jones, B.J. et al, Microinjections of methyl-beta-carboline-3-carboxylate into the dorsal raphe nucleus : behavioral consequences. Pharmacol. Biochem. Behav. 1986 / 24 (5) / 1487-1489. , File, S.E. et al, Actions of the beta-carboline ZK93426 in an animal test of anxiety and the holeboard : interactions with Ro15-1788. J. Neural. Transm. 1986 / 65 (2) / 103-114.
(36) De Boer, S.F. et al, Common mechanisms underlying the proconflict effects of corticotropin, a benzodiazepine inverse agonist and electric foot shock. J. Pharmacol. Exp. Ther. 1992 / 262 (1) / 335-342.
(37) Maiewski, S.F. et al, Evidence that a benzodiazepine receptor mechanism regulates the secretion of pituitary beta-endorphin in rats. Endocrinology 1985 / 117 (2) / 474-480.
(38) Funayama, Y. et al, Effects of beta- and gamma-carboline derivates of DNA topoisomerase activities. Mutat. Res. 1996 / 349 (2) / 183-191.
(39) Medina, J.A. et al, n-(3H)Butyl-beta-carboline-3-carboxylate, a putative endogenous ligand ,binds preferentially to subtype 1 of central benzodiazepine receptors. J. J. Neurochem. 1989 / 52 (3) / 665-670. , Novas, M.L. et al, Proconvulsant and 'anxiogenic' effects of n-butyl-beta-carboline-3-carboxylic acid, an endogenous benzodiazepine binding inhibitor from brain. Pharmacol. Biochem. Behav. 1988 / 30 (2) / 331-336.
(40) White, G. et al, Benzodiazepine site inverse agonists can selectively inhibit subtypes of the gamma-aminobutyric acidA receptor. Neuroreport 1995 / 6 (9) / 1313-1316. , Corda, M.G. et al, Functional coupling of GABAA receptors and benzodiazepine recognition site subtypes in the spinal cord of the rat. Eur. J. Pharmacol. 1989 / 169 (2-3) / 205-213.
(41) Petersen, E.N. et al, Chronic treatment with lorazepam and FG7142 may change the effects of benzodiazepine receptor agonists, antagonists and inverse agonists by different mechanisms. eur. J. Pharmacol. 1987 / 133 (3) / 309-317.
(42) Laurie, D.J. et al, Flumazenil induces localised increases in glucose utilization during diazepam withdrawal in rats. Brain. Res. 1993 / 631 (2) / 277-286. , Little, H.J. et al, Chronic treatment with a benzodiazepine agonist in vivo increases the actions of the benzodiazepine partial inverse agonist FG7142, on the hippocampal slice in vitro. Brain. Res. 1992 / 573 (2) / 243-250. , Bitran, D. et al, Gestational exposure to diazepam increases sensitivity to convulsants that act at the GABA / benzodiazepine receptor complex. Eur. J. Pharmacol. 1991 / 196 (3) / 223-231. , Sannerud, C.A. et al, Behavioral effects of benzodiazepine ligands in non-dependent diazepam-dependent and diazepam-withdrawn baboons. Eur. J. Pharmacol. 1991 / 202 (2) / 159-169. , Little, H.J. et al, Chronic benzodiazepine treatment increases the effects of the inverse agonist FG7142. Neuropharmacology 1988 / 29 (4) / 741-745.
(43) Rogers, C.J. et al, Benzodiazepine and beta-carboline regulation of single GABA-A receptor channels of mouse spinal neurons in culture. J. Physiol. (Lond.) 1994 / 475 (1) / 69-82. , Malatynska, E. et al, Bidirectional effect of beta-carboline agonists at the benzodiazepine-GABA-A receptor chloride ionophore complex on GABA-stimulated 36Cl-uptake. Brain. Res. Bull. 1992 / 28 (4) / 605-611. , Pankaj, V. et al, Effects of prenatal exposure to benzodiazepine-related drugs on early development and adult social behaviour in Swiss mice -- 3. Inverse agonists. Gen. Pharmacol. 1991 / 22 (1) / 53-60. , Yakushiji, T. et al, Effects of benzodiazepines and non-benzodiazepine compounds on the GABA-induced response in frog isolated sensory neurons. Br. J. Pharmacol. 1989 / 98 (3) / 735-740. , File, S.E. et al, Low and high doses of benzodiazepine receptor inverse agonists respectively improve and impair performance in passive avoidance but do not affect habituation. Behav. Brain. Res. 1988 / 30 (1) / 31-36.
(44) Malatynska, E. et al, beta-Carboline interactions at the benzodiazepine-GABA receptor chloride-ionophore complex in the rat cerebral cortex. Brain. Res. Bull. 1989 / 22 (5) / 845-848.
(45) Ngur, D.O. et al, Modulation of GABA-stimulated CL-flux by a benzodiazepine agonist and 'inverse agonist' after chronic flurazepam treatment. Eur. J. Pharmacol. 1990 / 176 (3) / 351-356.
(46) Mathis, C. et al, Characterization of benzodiazepine-sensative behaviors in the A/J and C57BL/6J inbred strains of mice. Behav. Genet. 1994 / 24 (2) / 171-180.
(47) Moore, H. et al, Age-dependent modulation of in vivo cortical acetylcholine release by benzodiazepine receptor ligands. Brain. Res. 1992 / 596 (1-2) / 17-29. , Kochman, R.L. et al, Aging does not alter the sensitivity of benzodiazepine receptors to GABA modulation. Neurobiol. aging 1986 / 7 (5) / 363-365.
(48) Kemmerling, W., Toxicity of Palicourea marcgravii : combined effects of fluoracetate, N-methyltyramine and 2-methyl-tetrahydro-beta-carboline. Z. Naturforsch. (C) 1996 / 51 (1-2) / 59-64.
(49) Marley, R.J. ,Chronic administration of beta-carboline-3-carboxylic acid methylamide by continous intraventicular infusion increases GABAergic function. Neuropharmacology 1991 / 30 (3) / 245-251. , Porceddu, M.L. et al, Increase in nigral type 2 benzodiazepine recognition sites following striatonigral denervation. Eur. J. Pharmacol. 1985 / 112 (2) / 265-267.
(50) Rago, L. et al, Behavioral differences in an elevated plus maze : correlation between anxiety and decreased number of GABA and benzodiazepine receptors in mouse cerebral cortex. Naunyn Schmeidebergs Arch. Pharmacol. 1988 / 337 (6) / 675-678.
(51) Priolo, E. et al, Panic-like attack induced by microinfusion into the locus coeruleus of antagonists and inverse agonists at GABA-receptors in rodents. Funct. Neurol. 1991 / 6 (4) / 393-403.
(52) Huttunen, P. et al, Anatomical localization in hippocampus of tetrahydro-beta-carboline-induced alcohol drinking in rat. Alcohol 1987 / 4 (3) / 181-187. , Rommelspacher, H. et al, Harman induces preference for ethanol in rats : is the effect specific for ethanol ? Parhmacol. Biochem. Behav. 1987 / 26 (4) / 749-755.
(53) Allen, A.M. et al, Effects of lorazepam tolerance and withdrawal on GABAA receptor-operated chloride channels. J. Pharmacol. Exp. Ther. 1992 / 261 (2) / 395-402. , Buck, K.J. et al, Modulation of gamma-aminobutyric acid receptor-operated chloride channels by benzodiazepine inverse agonists is related to genetic differences in ethanol withdrawal seizure severity. J. Neurochem. 1991 / 57 (6) / 2100-2105.
(54) Mehta, A.K. et al, Chronic ethanol treatment alters the behavioral effects of Ro15-4513, a partially negative ligand for benzodiazepine binding sites. Brain. Res. 1989 / 489 (1) / 93-100.
(55) Buck, K.J. et al, Reversal of alcohol dependence and tolerance by a single administration of flumazenil. J. Pharmacol. Exp. Ther. 1991 / 257 (3) / 984-989. , Buck, K.J. et al, Benzodiazepine agonist and inverse agonist actions on GABAA-receptor-operated chloride channels. 1. Acute effects of ethanol. J. Pharmacol. Exp. Ther. 1990 / 253 (2) / 706-712. , Buck, K.J. et al, Benzodiazepine agonist and inverse agonist actions on GABAA-receptor-operated chloride channels. 2. Chronic effects of ethanol. J. Pharmacol. Exp. Ther. 1990 / 253 (2) / 713-719.
(56) Sanna, E. et al, Ex vivo binding of t-(35S)butylbicyclophosphorothionate : a biochemical tool to study the pharmacology of ethanol at the gamma-aminobutyric acid-coupled chloride channel. J. Pharmacol. Exp. Ther. 1991 / 256 (3) / 922-928. , Ehlers, C.L. et al, EEG effects of Ro15-4513 and FG7142 alone and in combination with ethanol. Pharmacol. Biochem. Behav. 1990 / 36 (3) / 607-611.
(57) Wu, W.J. et al, Suppression of splenic natural killer cell activity in a mouse model for binge drinking. 2. Role of the neuroendocrine system. J. Pharmacol. Exp. Ther. 1996 / 278 (3) / 1331-1339.
(58) Arora, P.K. et al, Suppression of cytotoxic T lymphocyte (CTL) activity by FG7142, a benzodiazepine receptor 'inverse agonist'. Immunopharmacology 1991 / 21 (2) / 91-97. , Petitto, J.M. et al, Suppression of natural killer cell activity by FG7142, a benzodiazepine receptor inverse agonist. Brain. Behav. Immun. 1989 / 3 (1) / 39-46. , Arora, P.K. et al, Suppression of the immune response by benzodiazepine receptor inverse agonists. J. Neuroimmunol. 1987 / 15 (1) / 1-9.
(59) Palluotto, F. et al, Structural-activity relationships of 2-aryl-2,5-dihydropyridazino(4,3-b) indol-3(3H)-ones at the benzodiazepine receptor. Bioorg. Med. Chem. 1996 / 4 (12) / 2091-2104. , Campagna, F. et al, 2-aryl-2,5-dihydropyridazino(4,3-b) indol-3(3H)-ones : novel rigid planar benzodiazepine receptor ligands. Bioorg. Med. Chem. 1993 / 1 (6) / 437-446.
(60) Lufty, K. et al, ACEA-1328, an NMDA receptor antagonist, increases the potency of morphine and K50,488H in the tail flick test in mice. Pharmacol. Res. 1998 / 35 (4) / 587-590.
(61) Mukhin, A.G. et al, Mitochondrial benzodiazepine receptors regulate steroid biosynthesis. Proc. Natl. Acad. Sci. U.S.A. 1989 / 86 (24) / 9813-9816. , Pellow, S. et al, The effects of putative anxiogenic compounds (FG7142, CGS8216 and Ro15-1788) on the rat corticosterone response. Physiol. Behav. 1985 / 35 (4) / 587-590.
(62) Yerbury, R.E. et al, Novel benzodiazepine ligands : palatable food intake following zolpidem, CGS17867A, or Ro23-0364, in the rat. Pharmacol. Biochem. Behav. 1989 / 33 (2) / 303-307.
(63) Lista, A. et al, The benzodiazepine inverse agonist DMCM decreases serotonergic transmission in rat hippocampus : an in vivo electrophysiological study. Synapse 1990 / 6 (2) / 175-180. , Lista, A. et al, Benzodiazepine receptors modulate serotonine neurotransmission in the rat hippocampus : in vivo electrophysiological evidence. J. Pharmacol. Exp. Ther. 1990 / 254 (1) / 318-323. , Pawlik, M. et al, Quantitative autoradiograph of (3H)norharman ((3H)beta-carboline) binding sites in the rat brain. J. Chem. Neuroanal. 1990 / 3 (1) / 19-24. , Pei, Q. et al, Both systemic and local administration of benzodiazepine agonists inhibit the in vivo release of 5-HT from ventral hippocampus. Neuropharmacology 1989 / 28 (10) / 1061-1066. , Lista, A. et al, Modulation of the electrically evoked release of 5-(3H)hydroxytryptamine from rat cerebral cortex : effects of alpidem, CL218,872, and diazepam. J. Neurochem. 1988 / 51 (5) / 1414-1421. , Rovescalli, A.C. et al, Endocrine effects of 5-methoxytryptoline, 5-hydrotryptoline and tryptoline, putative modulators of rat serotonergic system. J. Endocrinol. Invest. 1987 / 10 (1) / 65-72. , Forchetti, C.M. et al, Evidence for a tonic GABAergic control of serotonin neurons in the median raphe nucleus. Brain. Res. 1981 / 206 (1) / 208-212.
(64) Nakane, H. et al, Stress-induced norepinephrine release in the rat prefrontal cortex measured by microdialysis. Am. J. Physiol. 1994 / 267 (6 Pt 2) / R1559-1566. , Ida, Y. et al, Anxiogenic beta-carboline FG7142 produces activity of neuroadrenergic neurons in specific brain regions of rats. Pharmacol. Biochem. Behav. 1991 / 39 (3) / 791-793. , De Boer, S.F. et al, Effects of chlordiazepoxide, flumazenil and DMCM on plasma catecholamine and corticosterone concentrations in rats. Pharmacol. Biochem. Behav. 1991 / 38 (1) / 13-19. , Stanford, S.C. et al, Effects of single or repeated administration of the benzodiazepine inverse agonist FG7142 on behaviour and cortical adrenoceptor binding in the rat. Psychopharmacology (Berl.) 1989 / 98 (3) / 417-424. , Yang, X.M. et al, Behavioral evidence for the role of noradrenaline in the putative anxiogenic actions of the inverse benzodiazepine receptor agonist methyl-4-6,7-dimethoxy-beta-carboline-carboxylate. J. Pharmacol. Exp. Ther. 1989 / 250 (1) / 358-363. , Fletcher, A. et al, A proconvulsive action of selective alpha 2 adrenoceptor antagonists. Eur. J. Pharmacol. 1988 / 151 (1) / 27-34. , Chopra, K. et al, Benzodiazepine inverse agonist FG7142-induced delayed behavioral depression in mice. Arch. Int. Pharmacodyn. Ther. 1988 / 294 / 56-63. , Stanford, S.C. et al, Chronic disipramine treatment prevents the upregulation of cortical beta-adrenoceptors caused by a single dose of the benzodiazepine inverse agonist FG7142. Eur. J. Pharmacol. 1987 / 139 (2) / 225-232. , Stanford, S.C. et al, Effects of chronic treatmentwith benzodiazepine receptor ligands on cortical adenoceptors. Eur J Pharmacol. 1986 / 129 (1-2) / 181-184. , Fung, S.C. et al, Multiple effects of drugs acting on benzodiazepine receptors. Neurosci. Lett. 1984 / 50 (1-3) / 203-207.
(65) Oades, R.D., Differential measures of 'sustained attention' in children with attention-deficit / hyperactivity or tic disorders : relations to monoamine metabolism. Psychiatry Res. 2000 / 93 (2) / 165-178. , Donovan, A.M. et al, Thermal response to serotonergic challenge and agression in attention deficit hyperactivity disorder children. J. Child. Adolesc. Psychopharmacol. 1999 / 9 (2) / 85-91. , Spivak, B. et al, Circulatory levels of catecholamines, serotonin and lipids in attention deficit hyperactivity disorder. Acta. Psychiatr. Scand. 1999 / 99 (4) / 300-304. , Oades, R.D. et al, Plasma neuropeptide-Y levels, monoamine metabolism, elektrolyte excretion and drinking behavior in children with attention-deficit hyperactivity disorder. Psychiatry Res. 1998 / 80 (2) / 177-186. , Ernst, M. et al, Selegiline in ADHD adults : plasma monoamines and monoamine metabolites. Neuropsychopharmacology 1997 / 16 (4) / 276-284. , Halperin, J.M. et al, Serotonin, agression, and parental psychopathology in children with attention-deficit hyperactivity disorder. J. Am. Acad. Child. Adolesc. Psychiatry 1997 / 36 (10) / 1391-1398. , Cook, E.H. Jr. et al, Attention deficit hyperactivity disorder and whole-blood serotonin levels : effects of comorbidity. Psychiatry Res. 1995 / 57 (1) 13-20. , Castellanos, F.X. et al, Cerebrospinal fluid monoamine metabolites in boys with attention-deficit hyperactivity disorder. Psychiatry Res. 1994 / 52 (3) / 305-316.
(66) Andersen, S.L. et al, Sex differences in dopamine receptors and their relevance to ADHD. Neurosci. Biobehav. Rev. 2000 / 24 (1) / 137-141. , Vallone, D. et al, Structure and function of dopamine receptors. Neurosci. Biobehav. Rev. 2000 / 24 (1) / 125-132. , Faraone, S.V. et al, Neurobiology of attention-deficit hyperactivity disorder. Biol. Psychiatry 1998 / 44 (10) / 951-958. , Carey, M.P. et al, Differential distribution ,affinity and plasticity of dopamine D-1 and D-2 receptors in the target sites of the mesolimbic system in an animal model of ADHD. Behav. Brain Res. 1998 / 94 (1) / 173-185. , Ernst, M. et al, Selegiline in ADHD adults : plasma monoamines and monoamine metabolites. Neuropsychopharmacology 1997 / 16 (4) / 276-284. , Hanna, G.L. et al, Urinary catecholamine excretion and behavioral differences in ADHD and normal boys. J. child. Adolesc. Psychopharmacol. 1996 / 6 (1) / 63-73. , Pliszka, S.R. et al, Catecholamines in attention-deficit hyperactivity disorder : current perspectives. J. Am. Acad. Child. Adolesc. Psychiatry 1996 / 35 (3) /264-272. , Castellanos, F.X. et al, Cerebrospinal fluid monoamine metabolites in boys with attention-deficit hyperactivity disorder. Psychiatry Res. 1994 / 52 (3) / 305-316. , Sverd, J. et al, Methylphenidate treatment of attention-deficit hyperactivity disorder in boys with Tourett's syndrome. J. Am. Acad. Child. Adolesc. Psychiatry. 1989 / 28 (4) / 580-582.
(67) Anderson, G.M. et al, Adrenomedullary funtion during cognitive testing in attention-deficit / hyperactivity disorder. J. Am. Acad. child. Adolesc. Psychiatry. 2000 / 39 (5) / 635-43. , Biederman, J. et al, Attention-deficit / hyperactivity disorder (ADHD) as a noradrenergic disorder. Biol. Psychiatry. 1999 / 46 (9) / 1234-1242. , Ernst, M. et al, Selegiline in ADHD adults : plasma monoamines and monoamine metabolites. Neuropsychopharmacology 1997 / 16 (4) / 276-284. , Halperin, J.M. et al, Noradrenergic mechanisms in ADHD children with and without reading disabilities : a replication and extension. J. Am. Acad. child. Adolesc. Psychiatry. 1997 / 36 (12) / 1688-1697. , Pliszka, S.R. et al, Catecholamines in attention-deficit hyperactivity disorder : current perspectives. J. Am. Acad. Child. Adolesc. Psychiatry 1996 / 35 (3) /264-272. , Hanna, G.L. et al, Urinary catecholamine excretion and behavioral differences in ADHD and normal boys. J. child. Adolesc. Psychopharmacol. 1996 / 6 (1) / 63-73. , Castellanos, F.X. et al, Cerebrospinal fluid monoamine metabolites in boys with attention-deficit hyperactivity disorder. Psychiatry Res. 1994 / 52 (3) / 305-316. , Pliszka, S.R. et al, Urinary catecholamines in attention-deficit hyperactivity disorder with and without comorbid anxiety. J. Am. Acad. Child Adolesc. Psychiatry 1994 / 33 (8) / 1165-1173.
(68) Mueser, K.T. et al, Conduct disorder ,antisocial personality disorder and substance use disorders in schizophrenia and major affective disorders. J. Stud. Alcohol. 1999 / 60 (2) / 278-284.
(69) Tsuchiya, M. et al, Enkephalinergic neurons express 5-HT3 receptors in the spinal cord dorsal horn : single cell RT-PCR analysis. Neuroreport 1999 / 10 (13) / 2749-2753. , Siniscalchi, A. et al, Inhibitory effect of noiciceptin on (3H)-5-HT release from rat cerebral cortex slices. Br. J. Pharmacol. 1999 / 128 (1) / 119-123.
(70) Schlicker, E. et al, Noiciceptin inhibits norepinephrine release in the mouse brain cortex via presynaptic CRL1 receptors. Naunyn Schmiedebergs Arch. Pharmacol. 1998 / 358 (4) / 418-422. , Quirarte, G.L. et al, Norepinephrine release in the amygdala in response to footshock and opioid peptidergic drugs. Brain Res. 1998 / 808 (2) / 134-140.